TR201819578A2 - Fesoterodi̇n fumaratin tablet kompozi̇syonlari - Google Patents

Fesoterodi̇n fumaratin tablet kompozi̇syonlari

Info

Publication number
TR201819578A2
TR201819578A2 TR2018/19578A TR201819578A TR201819578A2 TR 201819578 A2 TR201819578 A2 TR 201819578A2 TR 2018/19578 A TR2018/19578 A TR 2018/19578A TR 201819578 A TR201819578 A TR 201819578A TR 201819578 A2 TR201819578 A2 TR 201819578A2
Authority
TR
Turkey
Prior art keywords
tablet compositions
fesoterodine fumarate
fesoterodine
fumarate
relates
Prior art date
Application number
TR2018/19578A
Other languages
English (en)
Inventor
Akkaya Keri̇m
Pehli̇van Akalin Nur
Uslu Ezgi̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to EP18849451.2A priority Critical patent/EP3731829B1/en
Priority to PCT/TR2018/050860 priority patent/WO2019132832A1/en
Publication of TR201819578A2 publication Critical patent/TR201819578A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş; fesoterodin fumarat ve en az bir kaplama maddesi içeren, uzun süreli boyunca fesoterodin bozunmasına karşı stabil, uzatılmış salım sağlayantablet kompozisyonları ile ilgilidir. Mevcut buluş ayrıca, fesoterodin fumaratın uzatılmış salım sağlayantablet kompozisyonlarını hazırlamaya yönelik basit, hızlı, uygun maliyetli, zaman tasarrufu sağlayan ve endüstriyel olarak uygun bir yöntemle de ilgilidir.
TR2018/19578A 2017-12-25 2018-12-17 Fesoterodi̇n fumaratin tablet kompozi̇syonlari TR201819578A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP18849451.2A EP3731829B1 (en) 2017-12-25 2018-12-21 Tablet compositions of fesoterodine fumarate
PCT/TR2018/050860 WO2019132832A1 (en) 2017-12-25 2018-12-21 Tablet compositions of fesoterodine fumarate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/21437A TR201721437A2 (tr) 2017-12-25 2017-12-25 Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari

Publications (1)

Publication Number Publication Date
TR201819578A2 true TR201819578A2 (tr) 2019-07-22

Family

ID=67900979

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2017/21437A TR201721437A2 (tr) 2017-12-25 2017-12-25 Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
TR2018/19274A TR201819274A2 (tr) 2017-12-25 2018-12-13 Fesoterodi̇ni̇n uzatilmiş salim sağlayan kompozi̇syonlari
TR2018/19312A TR201819312A2 (tr) 2017-12-25 2018-12-13 Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu
TR2018/19578A TR201819578A2 (tr) 2017-12-25 2018-12-17 Fesoterodi̇n fumaratin tablet kompozi̇syonlari

Family Applications Before (3)

Application Number Title Priority Date Filing Date
TR2017/21437A TR201721437A2 (tr) 2017-12-25 2017-12-25 Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
TR2018/19274A TR201819274A2 (tr) 2017-12-25 2018-12-13 Fesoterodi̇ni̇n uzatilmiş salim sağlayan kompozi̇syonlari
TR2018/19312A TR201819312A2 (tr) 2017-12-25 2018-12-13 Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu

Country Status (3)

Country Link
EP (4) EP3731825A2 (tr)
TR (4) TR201721437A2 (tr)
WO (3) WO2019221684A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022073151A1 (en) * 2020-10-05 2022-04-14 Theracos Sub, Llc Pharmaceutical formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) 1999-11-16 2000-06-29 Schwarz Pharma Ag, 40789 Monheim Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen
US7807715B2 (en) 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
CN101466371B (zh) * 2006-06-09 2011-10-05 施瓦茨制药有限公司 含非索罗定的稳定的药用组合物
WO2010043408A2 (de) 2008-10-17 2010-04-22 Ratiopharm Gmbh Mikroverkapseltes fesoterodin
EP2508173A1 (en) * 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Stabilized pharmaceutical composition comprising fesoterodine
US20130236544A1 (en) * 2012-03-08 2013-09-12 Dr. Reddy's Laboratories Ltd. Stable pharmaceutical compositions of fesoterodine
ES2674811T3 (es) * 2012-07-02 2018-07-04 Hetero Research Foundation Composiciones estables de fesoterodina
US9629805B2 (en) * 2013-03-07 2017-04-25 Amneal Pharmaceuticals Llc Stabilization of moisture-sensitive drugs
WO2015022703A1 (en) * 2013-08-12 2015-02-19 Genepharm India Private Limited A stable pharmaceutical composition of fesoterodine hydrochloride
MX378845B (es) * 2014-01-21 2025-03-10 Bpsi Holdings Llc Revestimientos de pelicula de liberacion inmediata que contienen gliceridos de cadena media y sustratos revestidos con los mismos.

Also Published As

Publication number Publication date
WO2019221684A3 (en) 2020-01-30
EP3731829B1 (en) 2024-07-17
WO2019221684A2 (en) 2019-11-21
TR201819312A2 (tr) 2019-07-22
WO2019209220A3 (en) 2019-12-26
TR201819274A2 (tr) 2019-07-22
EP3731829A1 (en) 2020-11-04
EP3731826A2 (en) 2020-11-04
TR201721437A2 (tr) 2019-07-22
EP3731931B1 (en) 2025-11-26
WO2019194772A3 (en) 2020-01-02
EP3731825A2 (en) 2020-11-04
EP3731931A4 (en) 2021-11-03
WO2019209220A2 (en) 2019-10-31
WO2019194772A2 (en) 2019-10-10
EP3731931A2 (en) 2020-11-04
WO2019194772A9 (en) 2020-03-19

Similar Documents

Publication Publication Date Title
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
PH12017502255B1 (en) Nrf2 regulators
EA201892682A1 (ru) Пестицидные композиции
PL3582627T3 (pl) Formulacje stabilne podczas przechowywania
MX2021007914A (es) Composiciones curables que comprenden poliolefinas insaturadas.
MX376323B (es) Recubrimiento anti-microbiano y metodo para formar el mismo.
UA120058C2 (uk) Пестицидні композиції
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
TN2018000351A1 (en) Oxaborole esters and uses thereof
BR112018006314A2 (pt) composto da fórmula, composição, uso de composto da fórmula, método de combate a fungos fitopatogênicos e semente revestida
MX2016013890A (es) Composicion de champu que comprende matriz de gel e histidina.
EP3827810A4 (en) COSMETIC COMPOSITION WITH EXOSOME DERIVED FROM GALACTOMYCES AS ACTIVE INGREDIENT
MX2015015453A (es) Composicion acondicionadora para el cuidado del cabello que comprende histidina.
PL3850947T3 (pl) Kompozycja do zwalczania roztoczy mesostigmata
IL270273B1 (en) Highly charged drug formulations with enhanced sustained release
MX2016009520A (es) Composicion acondicionadora de cabello que comprende un zwitterion o material proteico.
TR201721824A2 (tr) Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon
IL274149A (en) Sustained release formulations for intra-articular applications
CR20140326A (es) Composiciones farmacéuticas tópicas que comprenden bexateno y corticosteroides
TR201819578A2 (tr) Fesoterodi̇n fumaratin tablet kompozi̇syonlari
EA032472B9 (ru) Композиция для укладки волос
EP3319595A4 (en) ENCAPSULATED ACTIVE SUBSTANCES FOR CONTROLLED ENTERAL ACTIVE COMPOSITION
BR112018003209A2 (pt) composição compreendendo uma lactama e um lactato de alquila ou alquenila